Industrialization’s eye view on theranostic nanomedicine [PDF]
The emergence of nanomedicines (NMs) in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.
Maharajan Sivasubramanian +4 more
doaj +2 more sources
Theranostic Nanomedicine for Malignant Gliomas [PDF]
Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant gliomas represent an incurable disease; indeed, after surgery and chemotherapy, recurrence appears within a few months, and mortality has remained high in the last ...
Michele d'Angelo +9 more
doaj +2 more sources
Advancements and Perspectives in Polysaccharide-Based Nanoparticles for Theranostic Nanomedicine [PDF]
It is with great enthusiasm [...]
Jingdi Chen
doaj +2 more sources
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform [PDF]
Exosomes have emerged as a promising cell-free therapeutic approach. However, challenges in large-scale production, quality control, and heterogeneity must be overcome before they can be used clinically.
Xiao Xu +5 more
doaj +2 more sources
Corrigendum: Theranostic Nanomedicine for Malignant Gliomas [PDF]
Michele d'Angelo +9 more
doaj +2 more sources
Editorial: Advanced Theranostic Nanomedicine in Oncology [PDF]
Christos Tapeinos +2 more
doaj +2 more sources
Design of Experiments Leads to Scalable Analgesic Near-Infrared Fluorescent Coconut Nanoemulsions [PDF]
Background: Pain is a complex phenomenon characterized by unpleasant experiences with profound heterogeneity influenced by biological, psychological, and social factors. According to the National Health Interview Survey, 50.2 million U.S.
Amit Chandra Das +6 more
doaj +2 more sources
Theranostic nanomedicine: Potential therapeutic epitome
Upendra Nagaich
doaj +2 more sources
Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation [PDF]
The nuclear factor kappa B (NF-κB) signalling pathway is a pivotal orchestrator of inflammation, tumour progression, immune modulation, and metabolic reprogramming within the dynamic landscape of the tumour microenvironment (TME).
Bandari BharathwajChetty +7 more
doaj +2 more sources
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic diseases in the 21st century, with a high mortality rate. This review summarizes the various nanomedicines for diagnostic and therapeutic applications in CVRDs, including ...
Natasha Manners +9 more
doaj +1 more source

